Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Gossmann

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Surgical Research|May 9, 2006
Experimental radiofrequency ablation near the portal and the hepatic veins in pigs: differences in efficacy of a monopolar ablation systemChristopher Bangard, Axel Gossmann, Hans U Kasper, et al.
Anticancer Research|November 24, 2011
3D breast ultrasound: a significant predictor in breast cancer reduction under pre-operative chemotherapyMathias Warm, Volker Duda, Christian Eichler, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 27, 2008
Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agentChristopher Bangard, Dirk L Stippel, Frank Berg, et al.
Radiology|July 31, 2002
Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trialKarsten Krueger, Peter Landwehr, Mark Bendel, et al.
American Journal of Clinical Oncology|June 1, 2004
The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imagingHans Theodor Eich, Susanne Staar, Axel Gossmann, et al.
International Journal of Antimicrobial Agents|August 16, 2006
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young womanThomas Elter, Michal Sieniawski, Axel Gossmann, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2007
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG)Hans Theodor Eich, Axel Gossmann, Andreas Engert, et al.
Academic Radiology|August 22, 2002
Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?Robert C Brasch, Axel Gossmann, Thomas H Helbich, et al.
Annals of Neurology|October 2, 2003
Imaging-guided convection-enhanced delivery and gene therapy of glioblastomaJuergen Voges, Regina Reszka, Axel Gossmann, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 14, 2002
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiformeAxel Gossmann, Thomas H Helbich, Nagato Kuriyama, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Surgical Research|May 9, 2006
Experimental radiofrequency ablation near the portal and the hepatic veins in pigs: differences in efficacy of a monopolar ablation systemChristopher Bangard, Axel Gossmann, Hans U Kasper, et al.
Anticancer Research|November 24, 2011
3D breast ultrasound: a significant predictor in breast cancer reduction under pre-operative chemotherapyMathias Warm, Volker Duda, Christian Eichler, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 27, 2008
Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agentChristopher Bangard, Dirk L Stippel, Frank Berg, et al.
Radiology|July 31, 2002
Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trialKarsten Krueger, Peter Landwehr, Mark Bendel, et al.
American Journal of Clinical Oncology|June 1, 2004
The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imagingHans Theodor Eich, Susanne Staar, Axel Gossmann, et al.
International Journal of Antimicrobial Agents|August 16, 2006
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young womanThomas Elter, Michal Sieniawski, Axel Gossmann, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2007
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG)Hans Theodor Eich, Axel Gossmann, Andreas Engert, et al.
Academic Radiology|August 22, 2002
Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?Robert C Brasch, Axel Gossmann, Thomas H Helbich, et al.
Annals of Neurology|October 2, 2003
Imaging-guided convection-enhanced delivery and gene therapy of glioblastomaJuergen Voges, Regina Reszka, Axel Gossmann, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 14, 2002
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiformeAxel Gossmann, Thomas H Helbich, Nagato Kuriyama, et al.
Pageof 4